Techniques in Vascular & Interventional Radiology
Volume 7, Issue 4 , Pages 194-195, December 2004

CaRESS: Carotid Revascularization Using Endarterectomy or Stenting Systems

  • CaRESS Steering Committee

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Sonja McKinlay, PhD, New England Research Institutes, Inc., 9 Galen Street, Watertown, MA 02472 USA. E-mail: sonjam@neri.org.

The primary objective of the CaRESS Phase I trial is to determine the sample size needed to reliably test the hypothesis that carotid stenting systems with distal embolic protection (CAS) is equivalent to carotid endarterectomy (CEA) in the treatment of symptomatic and asymptomatic carotid artery disease in a broad-risk population. A total of 397 patients were treated at 14 clinical centers. The primary endpoint results of combined all-cause mortality and stroke at 30-days and 1-year are presented. The CaRESS Phase I study was able to closely resemble clinical practice and results suggest equivalence between treatment groups.

Keywords:  clinical trial , carotid endarterectomy , carotid stenting , stroke

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Affiliations for the members of the CaRESS Steering Committee appear in the acknowledgment section at the end of the article.Funds for the Phase 1 CaRESS Clinical Trial were provided to the International Society of Endovascular Specialists, which sponsored the Investigational Device Exemption, by Boston Scientific Corporation, Natick, MA and Medtronic, AVE, Santa Rosa, CA, USA.

PII: S1089-2516(05)00019-3

doi:10.1053/j.tvir.2005.03.009

Refers to erratum:

  • Erratum

    Techniques in Vascular & Interventional Radiology June 2005 (Vol. 8, Issue 2, Page 103)

Techniques in Vascular & Interventional Radiology
Volume 7, Issue 4 , Pages 194-195, December 2004

Article Tools